T0	Limitation 28201 28206	Lyden
T1	Limitation 28420 28423	The
T2	Limitation 29253 29256	The
T3	Limitation 29710 29713	The
T4	Limitation 29879 29887	However,
T5	Limitation 31316 31321	Lyden
T6	Limitation 32129 32132	Our
T7	SampleSize 28262 28330	IST-3 recruited only half the number of patients originally intended
T8	SampleSize 28637 28679	our failing to achieve our original target
T9	Blinding 29253 29275	The absence of masking
T10	Patient 29710 29835	The self-assessment at 6 months by patients or their carer by postal questionnaire or masked telephone interview was unmasked
T11	PrecisionOfMeasurement 29888 29947	self-reported outcome by patients is necessarily subjective
T12	OutcomeMeasures 31341 31434	the sampling approach to monitoring in IST-3 was less intense than in many commercial studies
T13	UnderpoweredStudy 32129 32201	Our trial was underpowered to reliably detect important subgroup effects
T14	UnderpoweredStudy 28338 28419	was underpowered for the primary outcome (and more so for the subgroup analyses).
